• 8105 Citations
  • 44 h-Index
1984 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 17 Similar Profiles
Thromboplastin Medicine & Life Sciences
Thrombin Medicine & Life Sciences
Factor VIIa Medicine & Life Sciences
Blood Platelets Medicine & Life Sciences
Factor IX Medicine & Life Sciences
Factor IXa Medicine & Life Sciences
Hemostasis Medicine & Life Sciences
Hemophilia B Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2018

Prohemostatic compounds

Monroe, D. M.

Industry Sponsor

8/1/152/1/16

Project: Research project

Hemophilia A
Tranexamic Acid
Factor IX
Blood Coagulation Factors
Factor VIII

SBIR: Chimeric FVIIa

Stafford, D. W. & Monroe, D. M.

Industry Sponsor

4/1/159/30/16

Project: Research project

Hemophilia A
Hemorrhage
Factor VIII
Half-Life
Factor VIIa
Hemophilia B
Hematoma
Hemorrhage
Joints
Wounds and Injuries
Antithrombins
Thrombin
Heparin
Antithrombin III
Thoracic Surgery

Research Output 1984 2018

Factor XI promotes hemostasis in factor IX-deficient mice

Mohammed, B. M., Cheng, Q., Matafonov, A., Monroe, D. M., Meijers, J. C. M. & Gailani, D., Oct 1 2018, In : Journal of Thrombosis and Haemostasis. 16, 10, p. 2044-2049 6 p.

Research output: Contribution to journalArticle

Factor XI
Factor IX
Hemostasis
Saphenous Vein
Hemorrhage

In vitro characterization of MOD-5014, a novel long-acting carboxy-terminal peptide (CTP)-modified activated FVII

Bar-Ilan, A., Livnat, T., Hoffmann, M., Binder, L., Zakar, M., Guy, R., Felikman, Y., Moschcovich, L., Shenkman, B., Monroe, D. M., Hershkovitz, O., Kenet, G. & Hart, G., May 1 2018, In : Haemophilia. 24, 3, p. 477-486 10 p.

Research output: Contribution to journalArticle

Blood Platelets
Hemophilia A
Thrombin
Peptides
Thrombelastography
9 Citations

Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis

Sun, J., Hua, B., Livingston, E. W., Taves, S., Johansen, P. B., Hoffman, M., Ezban, M., Monroe, D. M., Bateman, T. A. & Monahan, P. E., Apr 13 2017, In : Blood. 129, 15, p. 2161-2171 11 p.

Research output: Contribution to journalArticle

Hemarthrosis
Factor IX
Hemophilia A
Wound Healing
Bone

Harold Ross Roberts, MD, 1930-2017

Monroe, D. M. & Key, N. S., Jan 1 2017, (Accepted/In press) In : Haemophilia.

Research output: Contribution to journalArticle

Impact of non-Vitamin K antagonist oral anticoagulants from a basic science perspective

Hoffman, M. & Monroe, D. M., Jan 1 2017, In : Arteriosclerosis, thrombosis, and vascular biology. 37, 10, p. 1812-1818 7 p.

Research output: Contribution to journalArticle

Anticoagulants
Peptide Hydrolases
Vitamin K
Pharmaceutical Preparations
Safety